Crossmark

Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy

Crossref DOI link: https://doi.org/10.1039/C8BM00899J

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Yang, Bin

Wang, Kaiyuan

Zhang, Dong

Sun, Bingjun

Ji, Bin

Wei, Lin

Li, Zhenbao

Wang, Menglin

Zhang, Xuanbo

Zhang, Haotian

Kan, Qiming

Luo, Cong

Wang, Yongjun

He, Zhonggui

Sun, Jin https://orcid.org/0000-0001-5470-1599
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81703451, 81473164, 81573371)

China Postdoctoral Science Foundation (2017M611269)
License Information

Accepted Manuscript valid from 2019-09-12
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Jin Sun (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 31 July 2018; Accepted 7 September 2018; Accepted Manuscript published 12 September 2018; Advance Article published 26 September 2018; Version of Record published 24 October 2018